People on the Move
VIEWPOINT: The federal program that fuels Delaware’s entrepreneurs
Cellergy Pharma adds Christopher Cano as CEO to lead allergy therapy efforts
Cellergy Pharma: Attacking Severe Allergies
Nemours - News Releases from Nemours
Cellergy Pharma Announces Phase I NIAID STTR Grant Award - Delaware BioScience Association
Cellergy Pharma receives $300K grant for cell therapies
Copyright © 2025 Cellergy Pharma, Inc. - All Rights Reserved.
Powered by
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.